AUSTIN — Minimus Spine Inc. has raised more than $925,000 of its $1.68 million equity offering, according to an SEC filing.
The Austin-based company, founded in 2006, develops ozone injection technology for spinal applications. Minimus Spine has built advanced prototypes and is performing tests.
The company is privately held and financed by several angel investors in the United States , Europe and the Middle East . Most of the investors are spine clinicians or medical device executives, according to Minimus Spine’s Web site.
The sole principal named in the filing is President and CEO David Hooper.
Reg D filing: http://tinyurl.com/2v9hx8y
Bio from Minimus Spine’s Web site:
David Hooper – President and CEO
David Hooper, Ph.D., was a technology executive with Spinal Concepts and Abbott Spine from 1999-2006 where he held responsibility for clinical and regulatory affairs, product development and business development. He was part of the executive management team through Abbott Labs acquisition of Spinal Concepts and Abbott Spine’s subsequent acquisition of SpineNext. Dr. Hooper completed his doctorate degree in biomedical engineering, focused on spinal mechanics, from the University of Iowa in 1996. He then spent three years at the University of East London studying rehabilitation following surgical reconstruction of knee ligaments. Dr. Hooper published several papers before leaving academia and entering the medical device industry.
Posted: June 6, 2010